BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10486920)

  • 1. Nontypeable Haemophilus influenzae: challenges in developing a vaccine.
    Kyd J; Cripps A
    J Biotechnol; 1999 Aug; 73(2-3):103-8. PubMed ID: 10486920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nontypeable Haemophilus influenzae disease: epidemiology, pathogenesis, and prospects for prevention.
    St Geme JW
    Infect Agents Dis; 1993 Feb; 2(1):1-16. PubMed ID: 8162349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen.
    Duell BL; Su YC; Riesbeck K
    FEBS Lett; 2016 Nov; 590(21):3840-3853. PubMed ID: 27508518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress toward molecular determinants of the pathogenesis of disease due to nontypeable Haemophilus influenzae].
    Tian GZ; Zhang L; Shao ZJ
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):174-9. PubMed ID: 20077666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.
    Khan MN; Ren D; Kaur R; Basha S; Zagursky R; Pichichero ME
    Expert Rev Vaccines; 2016 Jul; 15(7):863-78. PubMed ID: 26894630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why we need a vaccine for non-typeable Haemophilus influenzae.
    Cerquetti M; Giufrè M
    Hum Vaccin Immunother; 2016 Sep; 12(9):2357-61. PubMed ID: 27171854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunity to antigens of nontypeable Haemophilus influenzae strains].
    Orlova OE; Vaneeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):115-21. PubMed ID: 18038557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine.
    Poolman JT; Bakaletz L; Cripps A; Denoel PA; Forsgren A; Kyd J; Lobet Y
    Vaccine; 2000 Dec; 19 Suppl 1():S108-15. PubMed ID: 11163473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
    Murphy TF
    Clin Vaccine Immunol; 2015 May; 22(5):459-66. PubMed ID: 25787137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontypeable Haemophilus influenzae as a pathogen in children.
    Murphy TF; Faden H; Bakaletz LO; Kyd JM; Forsgren A; Campos J; Virji M; Pelton SI
    Pediatr Infect Dis J; 2009 Jan; 28(1):43-8. PubMed ID: 19057458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung.
    Webb DC; Cripps AW
    Infect Immun; 1999 May; 67(5):2138-44. PubMed ID: 10225866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine.
    Hare KM; Smith-Vaughan HC; Leach AJ; Pizzutto SJ; McCallum GB; Chang AB
    Vaccine; 2018 Mar; 36(13):1736-1742. PubMed ID: 29478754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.
    Hua CZ; Hu WL; Shang SQ; Li JP; Hong LQ; Yan J
    Clin Vaccine Immunol; 2016 Feb; 23(2):155-61. PubMed ID: 26677200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontypeable Haemophilus influenzae (NTHi).
    Bakaletz LO; Novotny LA
    Trends Microbiol; 2018 Aug; 26(8):727-728. PubMed ID: 29793827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontypeable Haemophilus influenzae: pathogenesis and prevention.
    Foxwell AR; Kyd JM; Cripps AW
    Microbiol Mol Biol Rev; 1998 Jun; 62(2):294-308. PubMed ID: 9618443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHiD-CV induces anti-Protein D antibodies but does not augment pulmonary clearance of nontypeable Haemophilus influenzae in mice.
    Siggins MK; Gill SK; Langford PR; Li Y; Ladhani SN; Tregoning JS
    Vaccine; 2015 Sep; 33(38):4954-61. PubMed ID: 26212006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary
    Li W; Zhang X; Yang Y; Yin Q; Wang Y; Li Y; Wang C; Wong SM; Wang Y; Goldfine H; Akerley BJ; Shen H
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7149-E7157. PubMed ID: 29987031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling Haemophilus influenzae virulence mechanisms enable discovery of new targets for antimicrobials and vaccines.
    Langereis JD; de Jonge MI
    Curr Opin Infect Dis; 2020 Jun; 33(3):231-237. PubMed ID: 32304471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.
    Winter LE; Barenkamp SJ
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of an important vaccine and diagnostic target in carriage- and disease-related nontypeable Haemophilus influenzae.
    Smith-Vaughan HC; Chang AB; Sarovich DS; Marsh RL; Grimwood K; Leach AJ; Morris PS; Price EP
    Clin Vaccine Immunol; 2014 Feb; 21(2):250-2. PubMed ID: 24285816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.